Educational Intervention to Minimize Disparities in Humanpapillomavirus Vaccination

While HPV infection is nearly ubiquitous among the sexually active population, the morbidity
and mortality from HPV-related diseases disproportionately affects minorities and the poor.
Hispanic women are at particularly high risk as they have the highest rates of invasive
cervical cancer when compared to all other racial or ethnic groups in the U.S. Initiating
the 3-dose HPV vaccination series is more common among Hispanic adolescents than whites, but
series completion has been lowest among Hispanic populations.

To understand barriers to HPV vaccination and to provide insight into ways in which an
existing educational intervention should be modified for a Hispanic population, the
investigators conducted focus groups among Hispanic parents and Latina young adults. All
groups reported vaccine cost, access to insurance, and a general lack of awareness and/or
understanding of either HPV or the vaccine as barriers. All groups also wanted substantially
more "general" information about both HPV and the vaccine in order to make informed
vaccination decisions. The educational intervention was generally well received but there
were universal suggestions from all the groups to provide additional basic information about
HPV infection, to add information about the vaccine for boys/young men, and to modify the
color scheme and logo to make it more eye-catching and pleasing.

This next phase of the project will be comprised of real world testing of an iPad-based
educational intervention about HPV, "Combatting HPV Infection and Cancer" (CHICOS) that has
been revised and developed per focus group feedback to target the Hispanic population.

By providing information that patients and parents have clearly indicated they want in a way
that is culturally sensitive and meaningful and also individually personalized, the
investigators hope to improve both the HPV vaccination decision-making process and HPV
vaccination rates.

Inclusion Criteria:

1. Parents of an adolescent between the ages of 9-17; OR a young adult patient between
the ages of 18-26;

2. Adolescent/young adult has not yet received all three doses of the HPV vaccine.

3. Parent/young adult can read and converse in either English or Spanish

Exclusion Criteria:

1. Age <18,

2. Prisoners

3. Decisionally challenged subjects

4. Those who cannot read and converse in either English or Spanish

5. Those who have received all 3 doses of the HPV vaccine